Learn how LA stiffness index offers superior diagnostic accuracy in estimating LVFPs in acute heart failure, paving the way ...

Motorists are required to tell the DVLA about any medical conditions that could affect their driving or they could face a ...

BACKGROUND: Coagulation factor XI (FXI) inhibitors are a promising and novel class of anticoagulants, but a recent animal study found that FXI inhibition exacerbated diastolic dysfunction and heart ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible ...

Approximately €70 Million in Upfront and Near-term Payments to Cytokinetics Up to €490 Million in Commercial Milestone Payments, withTiered Royalties on Future Sales SOUTH SAN FRANCISCO, Calif. and ...

Cytokinetics, Incorporated (Nasdaq: CYTK) and Bayer today announced they have entered into a collaboration and license agreement for the exclusive development and commercialization of aficamten in ...

Tecarfarin has an orphan drug designation for left ventricular assist device (LVAD) patients and both orphan drug and fast-track designations for end-stage kidney disease patients with atrial ...

Using an artificial intelligence program to read echocardiograms may reduce the wait time for results and help lead to more ...

Of the 518 hospitals that had at least 10 eligible discharges, only 11 of them prescribed SGLT2 inhibitors to more than half ...

You have to manage your heart health to maintain a healthy life even when you get older. According to the recently released ...